PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Medlive Technology Co Ltd (2192.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINKYG5961B1041
SectorHealthcare
IndustryMedical Distribution

Highlights

Market CapHK$5.49B
PE Ratio20.97
PEG Ratio2.91
Total Revenue (TTM)HK$173.51M
Gross Profit (TTM)HK$105.22M
Year RangeHK$5.42 - HK$9.72
Target PriceHK$10.54

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Medlive Technology Co Ltd

Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in Medlive Technology Co Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%2024FebruaryMarchAprilMayJune
-3.35%
15.26%
2192.HK (Medlive Technology Co Ltd)
Benchmark (^GSPC)

S&P 500

Returns By Period

Medlive Technology Co Ltd had a return of -8.50% year-to-date (YTD) and 7.60% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-8.50%13.92%
1 month-7.52%3.57%
6 months-7.52%15.13%
1 year7.60%24.27%
5 years (annualized)N/A13.51%
10 years (annualized)N/A10.88%

Monthly Returns

The table below presents the monthly returns of 2192.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-27.12%20.23%1.62%10.33%-7.10%-8.50%
202326.85%-11.46%13.36%-20.26%-20.44%2.51%-6.01%6.55%13.00%-1.39%27.10%-13.29%1.83%
2022-53.60%-8.56%-31.54%17.72%-3.87%29.38%-13.52%25.65%-28.23%-24.67%43.36%-12.24%-68.57%
2021-1.13%7.34%14.44%7.44%-1.85%-31.49%-12.26%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 2192.HK is 53, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of 2192.HK is 5353
2192.HK (Medlive Technology Co Ltd)
The Sharpe Ratio Rank of 2192.HK is 5555Sharpe Ratio Rank
The Sortino Ratio Rank of 2192.HK is 5353Sortino Ratio Rank
The Omega Ratio Rank of 2192.HK is 5050Omega Ratio Rank
The Calmar Ratio Rank of 2192.HK is 5252Calmar Ratio Rank
The Martin Ratio Rank of 2192.HK is 5353Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Medlive Technology Co Ltd (2192.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


2192.HK
Sharpe ratio
The chart of Sharpe ratio for 2192.HK, currently valued at 0.21, compared to the broader market-2.00-1.000.001.002.003.000.21
Sortino ratio
The chart of Sortino ratio for 2192.HK, currently valued at 0.67, compared to the broader market-4.00-2.000.002.004.006.000.67
Omega ratio
The chart of Omega ratio for 2192.HK, currently valued at 1.08, compared to the broader market0.501.001.502.001.08
Calmar ratio
The chart of Calmar ratio for 2192.HK, currently valued at 0.12, compared to the broader market0.002.004.006.000.12
Martin ratio
The chart of Martin ratio for 2192.HK, currently valued at 0.53, compared to the broader market-10.000.0010.0020.000.53
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.15, compared to the broader market-2.00-1.000.001.002.003.002.15
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.06, compared to the broader market-4.00-2.000.002.004.006.003.06
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.501.001.502.001.38
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.72, compared to the broader market0.002.004.006.001.72
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.07, compared to the broader market-10.000.0010.0020.008.07

Sharpe Ratio

The current Medlive Technology Co Ltd Sharpe ratio is 0.21. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Medlive Technology Co Ltd with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.002024FebruaryMarchAprilMayJune
0.21
2.13
2192.HK (Medlive Technology Co Ltd)
Benchmark (^GSPC)

Dividends

Dividend History

Medlive Technology Co Ltd granted a 3.33% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.25 per share.


PeriodTTM20232022
DividendHK$0.25HK$0.19HK$0.02

Dividend yield

3.33%2.25%0.25%

Monthly Dividends

The table displays the monthly dividend distributions for Medlive Technology Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024HK$0.00HK$0.00HK$0.00HK$0.00HK$0.14HK$0.00HK$0.14
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.07HK$0.00HK$0.00HK$0.00HK$0.00HK$0.12HK$0.00HK$0.19
2022HK$0.02HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.02

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%3.3%
Medlive Technology Co Ltd has a dividend yield of 3.33%, which is quite average when compared to the overall market.
Payout Ratio
20.0%40.0%60.0%80.0%100.0%120.0%54.0%
Medlive Technology Co Ltd has a payout ratio of 53.98%, which is quite average when compared to the overall market. This suggests that Medlive Technology Co Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%2024FebruaryMarchAprilMayJune
-82.51%
0
2192.HK (Medlive Technology Co Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Medlive Technology Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Medlive Technology Co Ltd was 87.26%, occurring on Aug 16, 2023. The portfolio has not yet recovered.

The current Medlive Technology Co Ltd drawdown is 82.51%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-87.26%Nov 12, 2021433Aug 16, 2023
-14.75%Aug 13, 202111Aug 27, 202119Sep 24, 202130
-12.42%Jul 16, 20219Jul 28, 20219Aug 10, 202118
-5.71%Oct 18, 20216Oct 25, 20212Oct 27, 20218
-5.52%Oct 5, 20212Oct 6, 20214Oct 12, 20216

Volatility

Volatility Chart

The current Medlive Technology Co Ltd volatility is 11.63%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%2024FebruaryMarchAprilMayJune
11.63%
2.46%
2192.HK (Medlive Technology Co Ltd)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Medlive Technology Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items